anurajms/meta_analysis huggingface dataset:
MESH terms:
Honey for acute cough in children
1. Albuterol [therapeutic use]; 2. Antitussive Agents [adverse effects, *therapeutic use]; 3. Apitherapy [adverse effects, *methods]; 4. Bromelains [therapeutic use]; 5. Bronchodilator Agents [therapeutic use]; 6. Cough [*therapy]; 7. Dextromethorphan [adverse effects, *therapeutic use]; 8. Diphenhydramine [adverse effects, *therapeutic use]; 9. Honey [adverse effects]; 10. Placebos [therapeutic use]; 11. Randomized Controlled Trials as Topic;
MESH terms:
Glucocorticosteroid‐free versus glucocorticosteroid‐containing immunosuppression for liver transplanted patients
1. Acute Disease; 2. Calcineurin Inhibitors [therapeutic use]; 3. Chronic Disease; 4. Diabetes Mellitus [prevention & control]; 5. Glucocorticoids [*administration & dosage, adverse effects]; 6. Graft Rejection [drug therapy, mortality, *prevention & control]; 7. Immunosuppression Therapy [*methods]; 8. Immunosuppressive Agents [*administration & dosage]; 9. *Liver Transplantation [mortality]; 10. Randomized Controlled Trials as Topic; 11. Renal Insufficiency [etiology]; 12. *Withholding Treatment;
MESH terms:
Ivermectin and permethrin for treating scabies
1. Administration, Oral; 2. Administration, Topical; 3. Antiparasitic Agents [administration & dosage, *therapeutic use]; 4. Ivermectin [administration & dosage, *therapeutic use]; 5. Permethrin [administration & dosage, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Scabies [*drug therapy]; 8. Treatment Outcome;
MESH terms:
Enteral nutritional therapy for induction of remission in Crohn's disease
1. Adrenal Cortex Hormones [therapeutic use]; 2. Crohn Disease [*therapy]; 3. Enteral Nutrition [*methods]; 4. Food, Formulated [analysis]; 5. Intention to Treat Analysis; 6. Parenteral Nutrition Solutions; 7. Randomized Controlled Trials as Topic; 8. Remission Induction [methods];
MESH terms:
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit
1. *Early Ambulation [adverse effects]; 2. *Exercise; 3. *Intensive Care Units; 4. Activities of Daily Living; 5. Critical Illness [*rehabilitation]; 6. Muscle Strength; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Respiration, Artificial;
MESH terms:
Oral versus inhaled antibiotics for bronchiectasis
1. Administration, Inhalation; 2. Administration, Oral; 3. Anti‐Bacterial Agents [*administration & dosage]; 4. Bronchiectasis [*drug therapy];
MESH terms:
Nutritional supplements for patients being treated for active visceral leishmaniasis
1. *Dietary Supplements; 2. *Nutrition Therapy; 3. Leishmaniasis, Visceral [*drug therapy]; 4. Malnutrition [*therapy];
MESH terms:
Vascular access specialist teams for device insertion and prevention of failure
1. *Cardiology; 2. *Vascular Access Devices; 3. Workforce;
MESH terms:
Immunoglobulin for alloimmune hemolytic disease in neonates
1. Anemia, Hemolytic [immunology, *therapy]; 2. Anemia, Neonatal [immunology, *therapy]; 3. Blood Transfusion; 4. *Immunoglobulins, Intravenous; 5. Jaundice, Neonatal [immunology, *therapy]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Laryngeal mask airway versus bag‐mask ventilation or endotracheal intubation for neonatal resuscitation
1. *Masks; 2. Hypoxia, Brain [etiology]; 3. Intensive Care Units, Neonatal [statistics & numerical data]; 4. Intubation, Intratracheal [instrumentation, methods]; 5. Laryngeal Masks; 6. Positive‐Pressure Respiration [instrumentation, *methods]; 7. Randomized Controlled Trials as Topic; 8. Resuscitation [instrumentation, *methods];
MESH terms:
Macrolide antibiotics for bronchiectasis
1. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 2. Azithromycin [adverse effects, therapeutic use]; 3. Bronchiectasis [*drug therapy]; 4. Clarithromycin [adverse effects, therapeutic use]; 5. Erythromycin [administration & dosage, therapeutic use]; 6. Macrolides [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Roxithromycin [adverse effects, therapeutic use];
MESH terms:
Systemic corticosteroids for acute otitis media in children
1. Acute Disease; 2. Adrenal Cortex Hormones [*therapeutic use]; 3. Anti‐Bacterial Agents [therapeutic use]; 4. Ceftriaxone [therapeutic use]; 5. Histamine Antagonists [therapeutic use]; 6. Otitis Media [*drug therapy]; 7. Randomized Controlled Trials as Topic;
MESH terms:
The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants
1. Behavior Observation Techniques [*methods]; 2. *Caregivers; 3. *Child Development; 4. *Interpersonal Relations; 5. Parent-Child Relations; 6. *Parents; 7. Randomized Controlled Trials as Topic;
MESH terms:
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs
1. Acetazolamide [*therapeutic use]; 2. Altitude Sickness [*prevention & control]; 3. Cathartics [adverse effects, *therapeutic use]; 4. Citric Acid [adverse effects, *therapeutic use]; 5. Diuretics [*therapeutic use]; 6. Organometallic Compounds [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Spironolactone [*therapeutic use]; 9. Sumatriptan [*therapeutic use];
MESH terms:
Standard (head‐down tilt) versus modified (without head‐down tilt) postural drainage in infants and young children with cystic fibrosis
1. Anti-Bacterial Agents [therapeutic use]; 2. Cystic Fibrosis [*complications]; 3. Disease Progression; 4. Drainage, Postural [*methods]; 5. Gastroesophageal Reflux [*etiology]; 6. Head-Down Tilt [adverse effects, *physiology]; 7. Lung [*metabolism]; 8. Mucus [metabolism]; 9. Randomized Controlled Trials as Topic; 10. Time Factors;
MESH terms:
Provision of respiratory support compared to no respiratory support before cord clamping for preterm infants
1. *Umbilical Cord; 2. Blood Transfusion [statistics & numerical data]; 3. Cerebral Intraventricular Hemorrhage [epidemiology]; 4. Constriction; 5. Continuous Positive Airway Pressure [methods, mortality]; 6. Hematocrit; 7. Hospital Mortality; 8. Hyperbilirubinemia [therapy]; 9. Hypotension [therapy]; 10. Infant, Premature; 11. Phototherapy [statistics & numerical data]; 12. Positive‐Pressure Respiration [*methods, mortality];
MESH terms:
Endovascular revascularisation versus conservative management for intermittent claudication
1. Cilostazol; 2. Combined Modality Therapy [methods]; 3. Conservative Treatment [*methods]; 4. Exercise Therapy; 5. Intermittent Claudication [*therapy]; 6. Randomized Controlled Trials as Topic; 7. Tetrazoles [therapeutic use]; 8. *Vascular Surgical Procedures; 9. Vasodilator Agents [therapeutic use];
MESH terms:
Interventions for autumn exacerbations of asthma in children
1. *Disease Progression; 2. *Seasons; 3. Acetates [therapeutic use]; 4. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 5. Anti‐Allergic Agents [adverse effects, *therapeutic use]; 6. Anti‐Asthmatic Agents [adverse effects, *therapeutic use]; 7. Asthma [epidemiology, *prevention & control]; 8. Behavior Therapy; 9. Chromones [therapeutic use]; 10. Cyclopropanes; 11. Leukotriene Antagonists [adverse effects, *therapeutic use]; 12. Omalizumab [adverse effects, therapeutic use]; 13. Quinolines [therapeutic use]; 14. Randomized Controlled Trials as Topic; 15. Sulfides;
MESH terms:
Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants
1. *Device Removal; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Catheter‐Related Infections [etiology, mortality, *prevention & control]; 4. Cause of Death; 5. Cefazolin [*therapeutic use]; 6. Central Venous Catheters [*adverse effects]; 7. Infant Mortality; 8. Sepsis [mortality, *prevention & control];
MESH terms:
Higher versus lower amino acid intake in parenteral nutrition for newborn infants
1. *Parenteral Nutrition; 2. Amino Acids [*administration & dosage]; 3. Child Development [*physiology]; 4. Developmental Disabilities [epidemiology]; 5. Infant Mortality; 6. Infant, Low Birth Weight; 7. Infant, Premature; 8. Randomized Controlled Trials as Topic; 9. Retinopathy of Prematurity [epidemiology];
MESH terms:
Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants
1. Adrenergic beta‐Antagonists [*therapeutic use]; 2. Angiogenesis Inhibitors [*therapeutic use]; 3. Cryotherapy; 4. Disease Progression; 5. Infant, Premature; 6. Laser Coagulation [methods]; 7. Propranolol [*therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Retinopathy of Prematurity [*prevention & control]; 10. Salvage Therapy [methods]; 11. Vascular Endothelial Growth Factor A [antagonists & inhibitors];
MESH terms:
Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight
1. *Achievement; 2. *Diet; 3. *Educational Status; 4. *Executive Function; 5. *Exercise; 6. *Life Style; 7. Mathematics; 8. Overweight [psychology, *therapy]; 9. Pediatric Obesity [psychology, *therapy]; 10. Randomized Controlled Trials as Topic; 11. Reading; 12. Sensitivity and Specificity;
MESH terms:
Slow‐release fluoride devices for the control of dental decay
1. Cariostatic Agents [*administration & dosage]; 2. DMF Index; 3. Delayed‐Action Preparations [administration & dosage]; 4. Dental Caries [*prevention & control]; 5. Fluorides [*administration & dosage]; 6. Glass; 7. Randomized Controlled Trials as Topic;
MESH terms:
Prostaglandin E1 for maintaining ductal patency in neonates with ductal‐dependent cardiac lesions
1. Alprostadil [adverse effects, *therapeutic use]; 2. Ductus Arteriosus, Patent [*drug therapy]; 3. Vasodilator Agents [adverse effects, *therapeutic use];
MESH terms:
Welfare‐to‐work interventions and their effects on the mental and physical health of lone parents and their children
1. *Child Health [ethics]; 2. Employment [economics, ethics, legislation & jurisprudence, *psychology]; 3. *Health Status; 4. Income; 5. Insurance, Health [statistics & numerical data]; 6. *Maternal Health [ethics]; 7. *Mental Health; 8. Poverty; 9. Randomized Controlled Trials as Topic; 10. Single Parent [*psychology]; 11. Social Welfare [ethics, legislation & jurisprudence, *psychology];
MESH terms:
BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization
1. *Anesthesia; 2. *Consciousness Monitors; 3. *Critical Illness; 4. *Intensive Care Units [statistics & numerical data]; 5. *Respiration, Artificial [adverse effects, statistics & numerical data]; 6. Length of Stay; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome;
MESH terms:
Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants
1. *Infant, Low Birth Weight; 2. Hypothermia [*prevention & control]; 3. Infant, Premature; 4. Infant, Premature, Diseases [*prevention & control]; 5. Perinatal Care [methods]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery
1. Administration, Oral; 2. *Bariatric Surgery [adverse effects]; 3. Bone Density [drug effects]; 4. Cause of Death; 5. Dietary Supplements; 6. Fractures, Bone; 7. Obesity [complications, surgery]; 8. Postoperative Complications [prevention & control]; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. *Vitamin D [administration & dosage, blood]; 12. *Vitamin D Deficiency [blood, complications, drug therapy]; 13. *Vitamins [administration & dosage];
MESH terms:
Midwife continuity of care models versus other models of care for childbearing women
1. Birth Weight; 2. Cesarean Section; 3. Continuity of Patient Care; 4. *Midwifery; 5. *Perinatal Death; 6. *Premature Birth [epidemiology]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Antioxidants for adults with chronic kidney disease
1. Antioxidants [adverse effects]; 2. *Cardiovascular Diseases [prevention & control]; 3. *Heart Failure; 4. *Kidney Failure, Chronic [therapy]; 5. *Renal Insufficiency, Chronic [complications];
MESH terms:
Synbiotics, prebiotics and probiotics for people with chronic kidney disease
1. Dysbiosis [complications, therapy]; 2. Indican; 3. Prebiotics; 4. *Probiotics [therapeutic use]; 5. *Renal Insufficiency, Chronic [complications, therapy]; 6. *Synbiotics; 7. Uremic Toxins;
MESH terms:
Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
1. Antioxidants [therapeutic use]; 2. beta Carotene; 3. Dietary Supplements; 4. *Geographic Atrophy [prevention & control]; 5. Lutein [therapeutic use]; 6. *Macular Degeneration [epidemiology, prevention & control]; 7. *Malnutrition; 8. Minerals; 9. Vitamin A; 10. Vitamin K; 11. Vitamins [therapeutic use]; 12. Zeaxanthins [therapeutic use]; 13. Zinc;
MESH terms:
Dance movement therapy for dementia
1. *Alzheimer Disease [therapy]; 2. *Cognitive Dysfunction [therapy]; 3. *Dance Therapy; 4. *Dancing; 5. Depression [therapy]; 6. Quality of Life;
MESH terms:
Low glycaemic index or low glycaemic load diets for people with overweight or obesity
1. Blood Glucose; 2. Body Weight; 3. Diet; 4. Glycemic Index; 5. *Glycemic Load; 6. Obesity; 7. *Overweight;
MESH terms:
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement
1. Plant Extracts [adverse effects]; 2. *Prostatic Hyperplasia [complications, drug therapy]; 3. Quality of Life; 4. Serenoa;
MESH terms:
Non‐Chinese herbal medicines for functional dyspepsia
1. *Complementary Therapies; 2. *Dyspepsia [drug therapy]; 3. Plant Extracts; 4. Quality of Life;
MESH terms:
Antidepressants for smoking cessation
1. Antidepressive Agents [adverse effects]; 2. Bupropion [adverse effects]; 3. Nicotinic Agonists [adverse effects]; 4. Nortriptyline [adverse effects]; 5. *Smoking Cessation [methods]; 6. Varenicline [adverse effects];
MESH terms:
Cephalic version by moxibustion for breech presentation
1. *Breech Presentation [therapy]; 2. Cesarean Section; 3. *Moxibustion [methods]; 4. Oxytocin; 5. Parturition; 6. *Premature Birth;
MESH terms:
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity
1. Apnea; 2. *Bronchopulmonary Dysplasia [prevention & control]; 3. Caffeine; 4. Infant, Extremely Premature; 5. *Infant, Premature, Diseases;
MESH terms:
The McKenzie method for (sub)acute non‐specific low back pain
1. *Acute Pain [therapy]; 2. Exercise Therapy; 3. *Low Back Pain [therapy]; 4. Quality of Life; 5. Treatment Outcome;
MESH terms:
Ultrasound and shockwave therapy for acute fractures in adults
1. *Extracorporeal Shockwave Therapy; 2. *Fractures, Stress; 3. *High-Energy Shock Waves; 4. Pain; 5. Randomized Controlled Trials as Topic; 6. Ultrasonography;
MESH terms:
Altered dietary salt intake for preventing diabetic kidney disease and its progression
1. *Diabetes Mellitus, Type 1; 2. *Diabetes Mellitus, Type 2 [complications, prevention & control]; 3. *Diabetic Nephropathies [prevention & control]; 4. *Hypertension [drug therapy]; 5. *Renal Insufficiency, Chronic [prevention & control]; 6. Sodium; 7. Sodium Chloride, Dietary [adverse effects];
MESH terms:
Yoga for chronic non‐specific low back pain
1. *Low Back Pain [therapy]; 2. Physical Therapy Modalities; 3. Quality of Life; 4. Treatment Outcome; 5. *Yoga;
MESH terms:
Ginkgo biloba for tinnitus
1. Ginkgo biloba; 2. Headache; 3. *Hypersensitivity; 4. Randomized Controlled Trials as Topic; 5. Seizures; 6. *Tinnitus [therapy];
MESH terms:
Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access
1. *Arteriovenous Fistula; 2. Exercise; 3. Renal Dialysis; 4. *Renal Insufficiency; 5. Upper Extremity;
MESH terms:
Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke
1. Activities of Daily Living; 2. Magnetic Phenomena; 3. Muscle Spasticity [rehabilitation]; 4. *Stroke [complications, therapy]; 5. *Stroke Rehabilitation [methods];
MESH terms:
Acupuncture for treating overactive bladder in adults
1. *Acupuncture Therapy [adverse effects, methods]; 2. *Nocturia; 3. Randomized Controlled Trials as Topic; 4. *Urinary Bladder Diseases; 5. *Urinary Bladder, Overactive [therapy]; 6. *Urinary Incontinence [therapy];
MESH terms:
Listening to music for insomnia in adults
1. Auscultation; 2. *Music; 3. Quality of Life; 4. Sleep; 5. *Sleep Initiation and Maintenance Disorders [therapy];
MESH terms:
Marine‐derived n‐3 fatty acids therapy for stroke
1. Fatty Acids; 2. *Fatty Acids, Omega-3 [therapeutic use]; 3. Fatty Acids, Unsaturated; 4. *Ischemic Attack, Transient [epidemiology]; 5. *Neuroprotective Agents [therapeutic use]; 6. *Stroke [epidemiology];
MESH terms:
Antioxidants for male subfertility
1. *Abortion, Spontaneous [epidemiology]; 2. Antioxidants [adverse effects]; 3. *Infertility, Female [drug therapy]; 4. *Infertility, Male [drug therapy, etiology]; 5. Live Birth [epidemiology]; 6. Pregnancy Rate;
MESH terms:
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
1. Anxiety [therapy]; 2. Anxiety Disorders [therapy]; 3. *Cognitive Dysfunction [therapy]; 4. *Dementia [complications, therapy]; 5. Depression [therapy]; 6. Quality of Life;
MESH terms:
Exercise training for adults undergoing maintenance dialysis
1. Exercise; 2. Fatigue [etiology]; 3. Quality of Life; 4. *Renal Dialysis; 5. *Resistance Training;
MESH terms:
Calcium supplementation for prevention of primary hypertension
1. Antihypertensive Agents [therapeutic use]; 2. Blood Pressure; 3. *Calcium; 4. Dietary Supplements; 5. *Hypertension [drug therapy, prevention & control];
MESH terms:
High versus low‐added sugar consumption for the primary prevention of cardiovascular disease
1. *Cardiovascular Diseases [epidemiology, prevention & control]; 2. Cholesterol; 3. Dietary Sugars [adverse effects]; 4. Primary Prevention; 5. Sugars;
MESH terms:
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults
1. Counseling; 2. *Malnutrition [etiology]; 3. *Nutrition Therapy; 4. Quality of Life; 5. Weight Gain;
MESH terms:
Effect of periodontal treatments on blood pressure
1. Blood Pressure; 2. *Cardiovascular Diseases; 3. *Chronic Periodontitis [therapy]; 4. *Hypertension [therapy];
MESH terms:
Mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors
1. Mental Health; 2. *Mindfulness; 3. Psychosocial Intervention; 4. Quality of Life; 5. *Students, Medical;
MESH terms:
Roselle for hypertension in adults
1. Blood Pressure; 2. *Cardiovascular Diseases; 3. *Hibiscus; 4. *Hypertension [drug therapy]; 5. Systole;
MESH terms:
Omega‐3 fatty acids for depression in adults
1. Antidepressive Agents [therapeutic use]; 2. Depression [drug therapy]; 3. *Depressive Disorder, Major [drug therapy]; 4. *Fatty Acids, Omega-3 [therapeutic use]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic;
MESH terms:
Humour‐based interventions for people with schizophrenia
1. Anxiety; 2. Anxiety Disorders; 3. Quality of Life; 4. *Schizophrenia [therapy]; 5. Systematic Reviews as Topic;
MESH terms:
Palliative care interventions in advanced dementia
1. Bias; 2. *Dementia [therapy]; 3. Family; 4. *Neurodegenerative Diseases; 5. Palliative Care; 6. Randomized Controlled Trials as Topic;
MESH terms:
Cannabinoids for the treatment of dementia
1. Activities of Daily Living; 2. *Alzheimer Disease [drug therapy]; 3. *Cannabidiol [therapeutic use]; 4. *Cannabinoids [adverse effects]; 5. *Dementia, Vascular;
MESH terms:
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
1. Bias; 2. Clomiphene [therapeutic use]; 3. Cyproterone Acetate [therapeutic use]; 4. Drug Combinations; 5. Drugs, Chinese Herbal [*therapeutic use]; 6. Ethinyl Estradiol [therapeutic use]; 7. Fertility Agents, Female [therapeutic use]; 8. Infertility, Female [*drug therapy, etiology]; 9. Laparoscopy; 10. Ovulation Induction [methods]; 11. Polycystic Ovary Syndrome [complications, *therapy]; 12. Pregnancy Rate; 13. Randomized Controlled Trials as Topic; 14. Suction;
MESH terms:
Ginseng for erectile dysfunction
1. Coitus; 2. Confidence Intervals; 3. Erectile Dysfunction [*drug therapy]; 4. *Panax; 5. Patient Satisfaction; 6. Phytotherapy [*methods]; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Probiotics for preventing gestational diabetes
1. Bias; 2. Cesarean Section [statistics & numerical data]; 3. Diabetes, Gestational [*prevention & control]; 4. Obesity; 5. Overweight; 6. Placebos [therapeutic use]; 7. Pre-Eclampsia [*etiology]; 8. Probiotics [adverse effects, *therapeutic use]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
1. Bias; 2. Blood Pressure [physiology]; 3. Cardiovascular Diseases [*prevention & control]; 4. Cholesterol [blood]; 5. *Diet, Vegan; 6. *Primary Prevention [statistics & numerical data]; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. *Secondary Prevention [statistics & numerical data]; 10. Triglycerides [blood];
MESH terms:
Coenzyme Q10 for heart failure
1. Ataxia; 2. *Heart Failure [drug therapy]; 3. Mitochondrial Diseases; 4. Muscle Weakness; 5. *Myocardial Infarction [drug therapy]; 6. Quality of Life; 7. *Stroke; 8. Stroke Volume; 9. Ubiquinone [adverse effects, analogs & derivatives, deficiency]; 10. Ventricular Function, Left;
MESH terms:
Intermittent fasting for the prevention of cardiovascular disease
1. Bias; 2. Blood Glucose [metabolism]; 3. Body Weight; 4. Caloric Restriction [methods]; 5. Cardiovascular Diseases [*prevention & control]; 6. *Fasting [adverse effects]; 7. Feeding Behavior; 8. Quality of Life; 9. Randomized Controlled Trials as Topic [statistics & numerical data]; 10. Time Factors;
MESH terms:
Souvenaid for Alzheimer's disease
1. Alzheimer Disease [*diet therapy]; 2. Bias; 3. Cognition; 4. Dementia [prevention & control]; 5. *Dietary Supplements [adverse effects]; 6. Disease Progression; 7. Docosahexaenoic Acids [adverse effects, chemistry, *therapeutic use]; 8. Eicosapentaenoic Acid [adverse effects, chemistry, *therapeutic use]; 9. Phospholipids [adverse effects, chemistry, *therapeutic use]; 10. Placebos [therapeutic use]; 11. Prodromal Symptoms; 12. Randomized Controlled Trials as Topic; 13. Time Factors;
MESH terms:
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
1. Aldosterone [blood]; 2. Asian People; 3. Bias; 4. Black People; 5. Blood Pressure [*drug effects]; 6. Catecholamines [blood]; 7. Cholesterol [blood]; 8. Confidence Intervals; 9. *Diet, Sodium-Restricted; 10. Epinephrine [blood]; 11. Hypertension [*diet therapy, ethnology]; 12. Norepinephrine [blood]; 13. Randomized Controlled Trials as Topic; 14. Recommended Dietary Allowances; 15. Renin [blood]; 16. Sodium Chloride, Dietary [*pharmacology]; 17. Triglycerides [blood]; 18. White People;
MESH terms:
Acupuncture for chronic nonspecific low back pain
1. Acupuncture Therapy [adverse effects, *methods]; 2. Bias; 3. Chronic Pain [*therapy]; 4. Confidence Intervals; 5. Low Back Pain [*therapy]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome;
MESH terms:
Melatonin for preoperative and postoperative anxiety in adults
1. Alprazolam [therapeutic use]; 2. Anti-Anxiety Agents [adverse effects, *therapeutic use]; 3. Anxiety [*drug therapy]; 4. Bias; 5. Clonidine [therapeutic use]; 6. Drug Administration Schedule; 7. Melatonin [adverse effects, *therapeutic use]; 8. Midazolam [therapeutic use]; 9. Oxazepam [therapeutic use]; 10. Postoperative Care; 11. Postoperative Complications [drug therapy, psychology]; 12. Preoperative Care; 13. Publication Bias; 14. Randomized Controlled Trials as Topic; 15. Surgical Procedures, Operative [*psychology];
MESH terms:
Iron chelators for acute stroke
1. Acute Disease; 2. Bias; 3. Deferoxamine [adverse effects, *therapeutic use]; 4. Hemorrhagic Stroke [*drug therapy, mortality]; 5. Iron Chelating Agents [adverse effects, *therapeutic use]; 6. Neuroprotective Agents [adverse effects, *therapeutic use]; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Pharmacotherapies for sleep disturbances in dementia
1. Alzheimer Disease [*complications]; 2. Azepines [adverse effects, therapeutic use]; 3. Caregiver Burden [drug therapy]; 4. Cognition [drug effects]; 5. Indenes [adverse effects, therapeutic use]; 6. Melatonin [adverse effects, therapeutic use]; 7. Pyridines [adverse effects, therapeutic use]; 8. Pyrimidines [adverse effects, therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Sleep [drug effects, physiology]; 11. Sleep Wake Disorders [*drug therapy, etiology]; 12. Time Factors; 13. Trazodone [adverse effects, therapeutic use]; 14. Triazoles [adverse effects, therapeutic use];
MESH terms:
Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke
1. *Activities of Daily Living; 2. Bias; 3. Cognition Disorders [rehabilitation]; 4. Confidence Intervals; 5. Lower Extremity [physiology]; 6. Motor Activity [physiology]; 7. Muscle Strength; 8. Patient Dropouts [statistics & numerical data]; 9. Perceptual Disorders [rehabilitation]; 10. Randomized Controlled Trials as Topic; 11. Recovery of Function; 12. *Stroke Rehabilitation; 13. *Transcranial Direct Current Stimulation; 14. Upper Extremity [physiology];
MESH terms:
Phlebotonics for venous insufficiency
1. 4-Aminobenzoic Acid [therapeutic use]; 2. Angioedemas, Hereditary [drug therapy]; 3. Calcium Dobesilate [therapeutic use]; 4. Centella; 5. Chronic Disease; 6. Diosmin [analogs & derivatives, therapeutic use]; 7. Edema [drug therapy]; 8. Hematologic Agents [*therapeutic use]; 9. Leg; 10. Leg Ulcer [drug therapy]; 11. para-Aminobenzoates [therapeutic use]; 12. Phytotherapy [methods]; 13. Pinus; 14. Plant Extracts [*therapeutic use]; 15. Quality of Life; 16. Randomized Controlled Trials as Topic; 17. Rutin [therapeutic use]; 18. Venous Insufficiency [*drug therapy];
MESH terms:
Low protein diets for non‐diabetic adults with chronic kidney disease
1. Bias; 2. Cause of Death; 3. Chronic Disease; 4. *Diet, Protein-Restricted; 5. *Disease Progression; 6. Glomerular Filtration Rate; 7. Kidney Failure, Chronic [*diet therapy, mortality, *prevention & control]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Magnesium for skeletal muscle cramps
1. Age Factors; 2. Cross-Over Studies; 3. Magnesium [adverse effects, *therapeutic use]; 4. Muscle Cramp [*drug therapy, etiology]; 5. *Muscle, Skeletal; 6. Placebos [therapeutic use]; 7. Pregnancy Complications [*drug therapy]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Antioxidants for female subfertility
1. Abortion, Spontaneous [epidemiology]; 2. Administration, Oral; 3. Antioxidants [*administration & dosage, adverse effects]; 4. Infertility, Female [*drug therapy]; 5. Live Birth [epidemiology]; 6. Minerals [administration & dosage]; 7. Oxidative Stress; 8. Pentoxifylline [adverse effects, therapeutic use]; 9. Placebos [administration & dosage]; 10. Pregnancy Rate; 11. Pregnancy, Multiple; 12. Randomized Controlled Trials as Topic; 13. Vitamins [administration & dosage];
MESH terms:
Reduction in saturated fat intake for cardiovascular disease
1. Cardiovascular Diseases [mortality, *prevention & control]; 2. Cause of Death; 3. Cholesterol [blood]; 4. Dietary Carbohydrates [administration & dosage]; 5. Dietary Fats [*administration & dosage]; 6. Dietary Fats, Unsaturated [administration & dosage]; 7. Dietary Proteins [administration & dosage]; 8. Energy Intake; 9. Fatty Acids [*administration & dosage]; 10. Myocardial Infarction [mortality, prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Stroke [prevention & control];
MESH terms:
Aromatherapy for dementia
1. *Aromatherapy; 2. Behavioral Symptoms [therapy]; 3. Bias; 4. Dementia [*therapy]; 5. Oils, Volatile [therapeutic use]; 6. Psychomotor Agitation [therapy]; 7. Randomized Controlled Trials as Topic;
MESH terms:
Therapeutic ultrasound for chronic low back pain
1. Bias; 2. Chronic Pain [*therapy]; 3. Electric Stimulation Therapy; 4. Exercise Therapy; 5. Low Back Pain [*therapy]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Ultrasonic Therapy [adverse effects, *methods];
MESH terms:
Tea tree oil for Demodex blepharitis
1. Anti-Infective Agents, Local [*therapeutic use]; 2. Blepharitis [*drug therapy, parasitology]; 3. Mite Infestations [complications, *drug therapy]; 4. Randomized Controlled Trials as Topic; 5. Tea Tree Oil [*therapeutic use];
MESH terms:
Dietary interventions for multiple sclerosis‐related outcomes
1. Antioxidants [*administration & dosage]; 2. Diet, Fat-Restricted; 3. Diet, Paleolithic; 4. Diet, Vegetarian; 5. *Dietary Supplements; 6. Disease Progression; 7. Fatty Acids, Monounsaturated [therapeutic use]; 8. Fatty Acids, Omega-3 [administration & dosage]; 9. Fatty Acids, Omega-6 [administration & dosage]; 10. Fatty Acids, Unsaturated [*administration & dosage]; 11. Multiple Sclerosis [*diet therapy]; 12. Randomized Controlled Trials as Topic; 13. Recurrence;
MESH terms:
Chelation therapy for atherosclerotic cardiovascular disease
1. Angina Pectoris [epidemiology]; 2. Arteriosclerosis [mortality, *therapy]; 3. Cause of Death; 4. Chelating Agents [*therapeutic use]; 5. Chelation Therapy [*methods, mortality]; 6. Coronary Artery Disease [mortality, therapy]; 7. Edetic Acid [*therapeutic use]; 8. Myocardial Infarction [epidemiology]; 9. Peripheral Vascular Diseases [mortality, *therapy]; 10. Randomized Controlled Trials as Topic; 11. Stroke [epidemiology];
MESH terms:
Probiotics for induction of remission in ulcerative colitis
1. Anti-Inflammatory Agents, Non-Steroidal [adverse effects, therapeutic use]; 2. Bias; 3. Colitis, Ulcerative [*therapy]; 4. Combined Modality Therapy [methods]; 5. Mesalamine [adverse effects, therapeutic use]; 6. Numbers Needed To Treat; 7. Probiotics [adverse effects, *therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Remission Induction [methods]; 10. Sample Size; 11. Sulfasalazine [therapeutic use];
MESH terms:
Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
1. *Dietary Supplements; 2. *Primary Prevention; 3. *Secondary Prevention; 4. Adiposity; 5. Arrhythmias, Cardiac [epidemiology]; 6. Cardiovascular Diseases [diet therapy, mortality, *prevention & control]; 7. Cause of Death; 8. Coronary Disease [mortality]; 9. Docosahexaenoic Acids [therapeutic use]; 10. Eicosapentaenoic Acid [therapeutic use]; 11. Fatty Acids, Omega‐3 [adverse effects, *therapeutic use]; 12. Hemorrhage [epidemiology]; 13. Pulmonary Embolism [epidemiology]; 14. Randomized Controlled Trials as Topic; 15. Regression Analysis; 16. Stroke [epidemiology]; 17. Treatment Outcome; 18. alpha‐Linolenic Acid [therapeutic use];
MESH terms:
Electrical stimulation for treating pressure ulcers
1. Electric Stimulation [*methods]; 2. Pressure Ulcer [*therapy]; 3. Randomized Controlled Trials as Topic; 4. Treatment Outcome; 5. Wound Healing;
MESH terms:
Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease
1. Dry Eye Syndromes [*drug therapy]; 2. Fatty Acids, Omega‐3 [*therapeutic use]; 3. Fatty Acids, Omega‐6 [*therapeutic use]; 4. Lubricant Eye Drops [administration & dosage]; 5. Ophthalmic Solutions [therapeutic use]; 6. Randomized Controlled Trials as Topic;
MESH terms:
Psychosocial interventions for preventing and treating depression in dialysis patients
1. Anxiety Disorders [*therapy]; 2. Cognitive Behavioral Therapy; 3. Depressive Disorder, Major [*therapy]; 4. Kidney Failure, Chronic [psychology, therapy]; 5. Psychotherapy [*methods]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Renal Dialysis [*psychology];
MESH terms:
Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis
1. Anastomosis, Surgical [*adverse effects]; 2. Anti‐Bacterial Agents [adverse effects, therapeutic use]; 3. Budesonide [adverse effects, therapeutic use]; 4. Ciprofloxacin [adverse effects, therapeutic use]; 5. Colitis, Ulcerative [*surgery]; 6. Enema; 7. Gastrointestinal Agents [adverse effects, therapeutic use]; 8. Metronidazole [adverse effects, therapeutic use]; 9. Postoperative Complications [drug therapy, prevention & control]; 10. Pouchitis [*drug therapy, etiology, prevention & control]; 11. Probiotics; 12. Randomized Controlled Trials as Topic; 13. Remission Induction;
MESH terms:
Animal‐assisted therapy for dementia
1. Activities of Daily Living; 2. *Animal Assisted Therapy; 3. *Cognition; 4. Dementia [*therapy]; 5. Depression [prevention & control, therapy]; 6. Dogs; 7. Horses; 8. Outcome Assessment, Health Care; 9. Randomized Controlled Trials as Topic;
MESH terms:
Biofeedback for treatment of irritable bowel syndrome
1. Feedback, Physiological [*physiology]; 2. Feedback, Psychological [*physiology]; 3. Irritable Bowel Syndrome [*therapy]; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome;
MESH terms:
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
1. Drugs, Chinese Herbal [*therapeutic use]; 2. Hepatitis B, Chronic [*drug therapy]; 3. Herbal Medicine; 4. Phytotherapy; 5. Randomized Controlled Trials as Topic;
MESH terms:
Interventions for pityriasis rosea
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Anti‐Inflammatory Agents [therapeutic use]; 3. Antiviral Agents [therapeutic use]; 4. Dermatologic Agents [therapeutic use]; 5. Histamine H1 Antagonists [therapeutic use]; 6. Phototherapy; 7. Pityriasis Rosea [*drug therapy]; 8. Pruritus [*drug therapy]; 9. Randomized Controlled Trials as Topic;
MESH terms:
Acupuncture for chronic hepatitis B
1. Acupuncture Therapy [*methods]; 2. Hepatitis B, Chronic [*therapy]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome;
MESH terms:
Acupuncture for polycystic ovarian syndrome
1. *Acupuncture Therapy; 2. Abortion, Spontaneous; 3. Cyproterone Acetate; 4. Drug Combinations; 5. Ethinyl Estradiol; 6. Infertility, Female [therapy]; 7. Menstruation; 8. Ovulation Induction [*methods]; 9. Polycystic Ovary Syndrome [*therapy]; 10. Pregnancy Outcome; 11. Pregnancy Rate; 12. Pregnancy, Multiple; 13. Randomized Controlled Trials as Topic;
MESH terms:
Melatonin and agomelatine for preventing seasonal affective disorder
1. Acetamides [*therapeutic use]; 2. Antidepressive Agents [*therapeutic use]; 3. Melatonin [agonists, *therapeutic use]; 4. Placebos [therapeutic use]; 5. Seasonal Affective Disorder [*prevention & control];
MESH terms:
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
1. Acetylcarnitine [administration & dosage, adverse effects, *therapeutic use]; 2. Diabetes Mellitus, Type 1 [*complications]; 3. Diabetes Mellitus, Type 2 [*complications]; 4. Diabetic Neuropathies [complications, *drug therapy]; 5. Neuralgia [*drug therapy]; 6. Pain Measurement; 7. Placebos [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Sensation [drug effects]; 10. Vibration; 11. Vitamin B 12 [administration & dosage, analogs & derivatives, therapeutic use];
MESH terms:
Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke
1. Aphasia [etiology, *therapy]; 2. Randomized Controlled Trials as Topic; 3. Recovery of Function; 4. Speech Therapy; 5. Stroke [*complications]; 6. Stroke Rehabilitation; 7. Transcranial Direct Current Stimulation [*methods];
MESH terms:
Yoga as part of a package of care versus non‐standard care for schizophrenia
1. *Yoga [psychology]; 2. Randomized Controlled Trials as Topic; 3. Schizophrenia [*therapy]; 4. Schizophrenic Psychology;
MESH terms:
Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
1. *Drugs, Chinese Herbal; 2. Hepatitis B, Chronic [*drug therapy]; 3. Plant Extracts [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Sophora [*chemistry]; 6. Treatment Outcome;
MESH terms:
Herbal medicinal products or preparations for neuropathic pain
1. Analgesics [therapeutic use]; 2. Chronic Pain [*drug therapy]; 3. Neuralgia [*drug therapy]; 4. *Phytotherapy; 5. Plant Extracts [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Treatment Outcome;
MESH terms:
Light therapy for preventing seasonal affective disorder
1. *Phototherapy; 2. Seasonal Affective Disorder [*prevention & control];
MESH terms:
Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
1. *Diet, Mediterranean; 2. Blood Pressure; 3. Cardiovascular Diseases [blood, mortality, *prevention & control]; 4. Cholesterol [blood]; 5. Cholesterol, HDL [blood]; 6. Cholesterol, LDL [blood]; 7. Primary Prevention [*methods]; 8. Randomized Controlled Trials as Topic; 9. Secondary Prevention [*methods];
MESH terms:
Yoga for treating urinary incontinence in women
1. Mindfulness [methods]; 2. Stress, Psychological [therapy]; 3. Treatment Outcome; 4. Urinary Incontinence, Stress [*therapy]; 5. Urinary Incontinence, Urge [*therapy]; 6. Waiting Lists; 7. *Yoga;
MESH terms:
Exercise for preventing falls in older people living in the community
1. *Exercise; 2. *Independent Living; 3. Accidental Falls [*prevention & control, statistics & numerical data]; 4. Dance Therapy [statistics & numerical data]; 5. Exercise Therapy [*statistics & numerical data]; 6. Fractures, Bone [epidemiology, prevention & control]; 7. Gait; 8. Postural Balance; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Resistance Training [statistics & numerical data]; 12. Tai Ji [statistics & numerical data];
MESH terms:
Iron for the treatment of restless legs syndrome
1. Dopamine Agonists [adverse effects, therapeutic use]; 2. Ferric Compounds [adverse effects, therapeutic use]; 3. Ferric Oxide, Saccharated [adverse effects, therapeutic use]; 4. Ferrous Compounds [adverse effects, therapeutic use]; 5. Iron [adverse effects, *therapeutic use]; 6. Maltose [adverse effects, analogs & derivatives, therapeutic use]; 7. Patient Dropouts [statistics & numerical data]; 8. Pramipexole [adverse effects, therapeutic use]; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Restless Legs Syndrome [*therapy]; 12. Trace Elements [adverse effects, *therapeutic use]; 13. Treatment Outcome;
MESH terms:
Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
1. *Caffeine; 2. *Central Nervous System Stimulants; 3. *Diet, Sodium‐Restricted; 4. *Sodium Chloride, Dietary; 5. Meniere Disease [*therapy]; 6. Syndrome;
MESH terms:
Single herbal medicine for diabetic retinopathy
1. China; 2. Diabetic Retinopathy [*drug therapy]; 3. Drugs, Chinese Herbal [therapeutic use]; 4. Ginsenosides [therapeutic use]; 5. Isoflavones [therapeutic use]; 6. Microaneurysm [prevention & control]; 7. Phytotherapy [*methods]; 8. Plants, Medicinal; 9. Pyrazines [therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Retinal Hemorrhage [prevention & control]; 12. Ruscus [chemistry]; 13. Saponins [therapeutic use]; 14. Vasodilator Agents [therapeutic use]; 15. Visual Acuity [drug effects];
MESH terms:
Acupuncture for symptomatic gastroparesis
1. Acupuncture Therapy [*methods]; 2. Benzamides [therapeutic use]; 3. Cimetidine [therapeutic use]; 4. Cisapride [therapeutic use]; 5. Diabetes Complications [etiology, therapy]; 6. Domperidone [therapeutic use]; 7. Gastrointestinal Agents [therapeutic use]; 8. Gastroparesis [etiology, *therapy]; 9. Histamine H2 Antagonists [therapeutic use]; 10. Morpholines [therapeutic use]; 11. Randomized Controlled Trials as Topic;
MESH terms:
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
1. Antioxidants [administration & dosage]; 2. Ascorbic Acid [administration & dosage]; 3. beta Carotene [administration & dosage]; 4. Calcium [administration & dosage]; 5. Cholecalciferol [administration & dosage]; 6. Cognition [*drug effects, physiology]; 7. Cognitive Dysfunction [*prevention & control]; 8. Copper [administration & dosage]; 9. Dementia [prevention & control]; 10. *Dietary Supplements; 11. Folic Acid [administration & dosage]; 12. Minerals [*administration & dosage]; 13. Randomized Controlled Trials as Topic; 14. Selenium [administration & dosage]; 15. Vitamin A [administration & dosage]; 16. Vitamin B 12 [administration & dosage]; 17. Vitamin B 6 [administration & dosage]; 18. Vitamin E [administration & dosage]; 19. Vitamins [*administration & dosage]; 20. Zinc [administration & dosage];
MESH terms:
Traditional Chinese herbal medicine for vascular dementia
1. *Dementia, Vascular [drug therapy]; 2. *Drugs, Chinese Herbal [therapeutic use]; 3. *Medicine, Chinese Traditional; 4. Randomized Controlled Trials as Topic;
MESH terms:
Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome
1. Acupuncture Points; 2. Acupuncture Therapy [adverse effects, *methods]; 3. Acupuncture, Ear; 4. Anti‐Inflammatory Agents, Non‐Steroidal [therapeutic use]; 5. Carpal Tunnel Syndrome [*therapy]; 6. Electroacupuncture [adverse effects, methods]; 7. Laser Therapy [adverse effects]; 8. Randomized Controlled Trials as Topic;
MESH terms:
Omega‐6 fats for the primary and secondary prevention of cardiovascular disease
1. *Blood Pressure; 2. Cardiovascular Diseases [mortality, *prevention & control]; 3. Cause of Death; 4. Cerebrovascular Disorders [prevention & control]; 5. Cholesterol [*blood]; 6. Cholesterol, HDL [blood]; 7. Cholesterol, LDL [blood]; 8. Fatty Acids, Omega‐6 [*administration & dosage]; 9. Myocardial Infarction [epidemiology, prevention & control]; 10. Primary Prevention [*methods]; 11. Randomized Controlled Trials as Topic; 12. Secondary Prevention; 13. Triglycerides [*blood];
MESH terms:
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
1. *Primary Prevention; 2. *Secondary Prevention; 3. Adiposity; 4. Arrhythmias, Cardiac [mortality, prevention & control]; 5. Cardiovascular Diseases [mortality, *prevention & control]; 6. Cause of Death; 7. Cholesterol [blood]; 8. Coronary Disease [mortality, prevention & control]; 9. Fatty Acids, Unsaturated [*administration & dosage, adverse effects]; 10. Lipoproteins, HDL [blood]; 11. Lipoproteins, LDL [blood]; 12. Randomized Controlled Trials as Topic; 13. Stroke [mortality, prevention & control]; 14. Triglycerides [blood]; 15. Weight Gain;
MESH terms:
Acupuncture for hypertension
1. *Acupuncture Therapy; 2. Angiotensin‐Converting Enzyme Inhibitors [therapeutic use]; 3. Antihypertensive Agents [therapeutic use]; 4. Calcium Channel Blockers [therapeutic use]; 5. Hypertension [drug therapy, *therapy]; 6. Publication Bias; 7. Randomized Controlled Trials as Topic;
MESH terms:
Cannabis for the treatment of Crohn's disease
1. *Phytotherapy [adverse effects]; 2. Cannabidiol [adverse effects, *therapeutic use]; 3. Crohn Disease [*drug therapy]; 4. Disease Progression; 5. Dronabinol [adverse effects, *therapeutic use]; 6. Marijuana Smoking; 7. Medical Marijuana [adverse effects, *therapeutic use]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Remission Induction;
MESH terms:
Rutosides for prevention of post‐thrombotic syndrome
1. Aesculus [*chemistry]; 2. Phytotherapy [*methods]; 3. Plant Extracts [*therapeutic use]; 4. Postthrombotic Syndrome [*prevention & control]; 5. Rutin [*therapeutic use]; 6. Venous Thrombosis [complications];
MESH terms:
Rutosides for treatment of post‐thrombotic syndrome
1. Aesculus [*chemistry]; 2. Phytotherapy [*methods]; 3. Placebos [therapeutic use]; 4. Plant Extracts [*therapeutic use]; 5. Postthrombotic Syndrome [*drug therapy, etiology, therapy]; 6. Randomized Controlled Trials as Topic; 7. Rutin [*therapeutic use]; 8. Stockings, Compression; 9. Venous Thrombosis [complications]; 10. Watchful Waiting;
MESH terms:
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
1. *Dietary Supplements; 2. Ascorbic Acid [*administration & dosage]; 3. Cognition [physiology]; 4. Cognition Disorders [*therapy]; 5. Dementia [*prevention & control]; 6. Executive Function; 7. Memory, Episodic; 8. Mortality; 9. Picolinic Acids [administration & dosage]; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Trace Elements [*administration & dosage]; 13. Vitamin B Complex [*administration & dosage]; 14. Vitamins [*administration & dosage]; 15. alpha‐Tocopherol [administration & dosage];
MESH terms:
Non‐clinical interventions for reducing unnecessary caesarean section
1. *Prenatal Education; 2. *Relaxation Therapy; 3. Anxiety [therapy]; 4. Cesarean Section [*statistics & numerical data]; 5. Controlled Before‐After Studies; 6. Guideline Adherence; 7. Interrupted Time Series Analysis; 8. Parturition [psychology]; 9. Randomized Controlled Trials as Topic; 10. Referral and Consultation [statistics & numerical data]; 11. Unnecessary Procedures [*statistics & numerical data]; 12. Vaginal Birth after Cesarean [statistics & numerical data];
MESH terms:
Vitamin D for the management of multiple sclerosis
1. Cholecalciferol [*therapeutic use]; 2. Ergocalciferols [*therapeutic use]; 3. Fatigue [drug therapy]; 4. Multiple Sclerosis [*drug therapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Vitamins [*therapeutic use];
MESH terms:
Art therapy for people with dementia
1. Art Therapy [*methods]; 2. Dementia [*therapy]; 3. Randomized Controlled Trials as Topic; 4. Recreation Therapy;
MESH terms:
Interventions for preventing falls in older people in care facilities and hospitals
1. *Hospitals [statistics & numerical data]; 2. *Nursing Homes [statistics & numerical data]; 3. Accidental Falls [*prevention & control, statistics & numerical data]; 4. Calcium, Dietary [administration & dosage]; 5. Exercise; 6. Randomized Controlled Trials as Topic; 7. Safety Management; 8. Vitamin D [administration & dosage]; 9. Vitamins [administration & dosage];
MESH terms:
Mindfulness‐based stress reduction for family carers of people with dementia
1. Anxiety [prevention & control]; 2. Caregivers [*psychology]; 3. Dementia [*nursing]; 4. Depression [prevention & control]; 5. Family [*psychology]; 6. Mindfulness [*methods]; 7. Patient Dropouts [statistics & numerical data]; 8. Randomized Controlled Trials as Topic; 9. Stress, Psychological [*prevention & control];
MESH terms:
Music‐based therapeutic interventions for people with dementia
1. *Music Therapy; 2. Aggression; 3. Dementia [psychology, rehabilitation, *therapy]; 4. Depression [therapy]; 5. Mental Disorders [therapy]; 6. Psychomotor Agitation [therapy]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Treatment Outcome;
MESH terms:
Prescribed hypocaloric nutrition support for critically‐ill adults
1. *Critical Illness [mortality]; 2. Caloric Restriction [*methods]; 3. Cause of Death; 4. Critical Care; 5. Enteral Nutrition [methods]; 6. Hospital Mortality; 7. Length of Stay; 8. Nutritional Support [*methods]; 9. Parenteral Nutrition [methods];
MESH terms:
Immersion in water during labour and birth
1. *Immersion; 2. *Labor Stage, First; 3. *Labor Stage, Second; 4. *Water; 5. Analgesia, Obstetrical [statistics & numerical data]; 6. Infant, Newborn, Diseases [epidemiology]; 7. Infections [epidemiology]; 8. Intensive Care Units, Neonatal [statistics & numerical data]; 9. Natural Childbirth; 10. Perineum [injuries]; 11. Randomized Controlled Trials as Topic;
MESH terms:
Non‐invasive brain stimulation techniques for chronic pain
1. Brain [*physiology]; 2. Chronic Pain [*therapy]; 3. Electric Stimulation Therapy [adverse effects, *methods]; 4. Pain Management [*methods]; 5. Randomized Controlled Trials as Topic; 6. Transcranial Magnetic Stimulation [adverse effects, *methods];
MESH terms:
Acupuncture for acute stroke
1. *Acupuncture Therapy; 2. Acute Disease; 3. Randomized Controlled Trials as Topic; 4. Stroke [*therapy];
MESH terms:
Relaxation techniques for pain management in labour
1. Analgesia, Obstetrical [*methods]; 2. Cesarean Section [statistics & numerical data]; 3. Labor Pain [*therapy]; 4. Mindfulness; 5. Music Therapy; 6. Pain Management [*methods]; 7. Pain Measurement; 8. Patient Satisfaction; 9. Randomized Controlled Trials as Topic; 10. Relaxation Therapy [*methods]; 11. Supine Position; 12. Yoga;